Stress-related mitochondrial components and mitochondrial genome as targets of anticancer therapy

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Mitochondria are crucial organelles regulating cell life and death.
• Mitochondrial structure and function are altered in cancer cells.
• Targeting mitochondria is an emerging anticancer therapeutic strategy.

Purpose of the Study:

• To review recent advancements in developing mitochondrial-targeted anticancer agents.
• To explore the molecular basis of targeting mitochondria, focusing on DNA mutations and dysfunction.
• To discuss candidate molecules affecting mitochondrial metabolism in cancer.

Main Methods:

• Literature review of scientific publications.
• Analysis of molecular mechanisms underlying mitochondrial roles in cancer.
• Examination of therapeutic strategies targeting mitochondrial defects.

Main Results:

• Mitochondrial alterations are common in cancer, offering therapeutic targets.
• Mitochondrial DNA mutations and dysfunction are key areas for drug development.
• Various compounds targeting mitochondrial metabolism show potential as anticancer agents.

Conclusions:

• Targeting mitochondria, particularly their genome and metabolic functions, is a promising strategy for cancer therapy.
• Further research into mitochondrial-targeted compounds could lead to novel anticancer treatments.
• Understanding mitochondrial dysfunction in cancer is key to developing effective therapies.